JRGD:LSE:LSE-JPMorgan ETFs (Ireland) ICAV - Global Research Enhanced Index Equity UCITS ETF - USD (dist) (USD)

ETF | Others |

Last Closing

USD 47.0225

Change

+0.08 (+0.16)%

Market Cap

USD 0.43B

Volume

485.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-05 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

+1.10 (+0.39%)

USD 292,109.69B
XMTD:LSE Xtrackers MSCI Taiwan UCITS ET..

+0.34 (+0.47%)

USD 292,109.19B
0R1O:LSE Amazon.com Inc.

-3.00 (-1.50%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

-3.28 (-2.46%)

USD 618.20B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.04 (+0.20%)

USD 586.49B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.05 (-0.36%)

USD 586.49B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
XDJP:LSE Xtrackers Nikkei 225 UCITS ETF..

-1.75 (-0.08%)

USD 329.34B
0QZK:LSE Coca-Cola Co.

+0.60 (+0.96%)

USD 266.08B
0QZO:LSE 0QZO

+0.30 (+0.31%)

USD 258.54B

ETFs Containing JRGD:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 13.75% 83% B 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.75% 82% B 78% C+
Trailing 12 Months  
Capital Gain 23.88% 80% B- 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 23.88% 80% B- 77% C+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 9.84% 69% C- 71% C-
Dividend Return 9.84% 69% C- 70% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.20% 64% D 79% B-
Risk Adjusted Return 96.41% 96% N/A 97% N/A
Market Capitalization 0.43B 67% D+ 50% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike